Investing
Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.
The accelerator project has created over 200 jobs in life sciences and medtech companies in the last five years, creating opportunity in an otherwise very expensive field
The startup uses machine learning and artificial intelligence algorithms to analyze a patient’s surgery risk and gives treatment recommendations.
The company also announced $44.13 million in revenue in Q3.
The company announced a $100 million Series E funding.
The company handles back-office operations for its partner organizations, and provides professional caregivers with an app for finding and scheduling jobs.
The funding was led by ETF and an investor consortium from across AI, science and analytics.
The proceeds will be used to drive product development and expand operations in the US.
Fortunis Capital has awarded Clementine a place in its top 20 UK Impact Investment Fund.